Combining treatments for alcoholism: why and how?

Area of Science:

• Addiction medicine
• Clinical psychology
• Psychopharmacology

Background:

• Alcohol use disorder is a complex, multifactorial condition requiring comprehensive treatment approaches.
• Emerging research highlights the biological, psychological, and social components of alcohol dependence.
• Single-modality treatments may be less effective than integrated approaches for alcohol use disorder.

Purpose of the Study:

• To evaluate the efficacy of combining pharmacotherapy and behavioral interventions for alcohol dependence.
• To assess the effectiveness of naltrexone and acamprosate, individually and in combination, with behavioral treatments.
• To provide background on the design and rationale of the COMBINE study.

Main Methods:

• The study employed a large, multisite clinical trial design.
• Investigated the combination of two medications (naltrexone, acamprosate) with two behavioral treatments of varying intensities.
• Utilized a combination of pharmacological and behavioral modalities for treating alcohol dependence.

Main Results:

• The COMBINE study aimed to determine if combined treatments improve outcomes for alcohol dependence.
• Evaluated the efficacy of naltrexone and acamprosate, singly and together.
• Assessed the impact of different intensities of behavioral interventions when combined with pharmacotherapy.

Conclusions:

• Combination treatment strategies are crucial for addressing the multifaceted nature of alcohol use disorder.
• The COMBINE study provides valuable insights into effective treatment paradigms for alcohol dependence.
• Future research directions in combination treatment for alcohol use disorder are discussed.